Anti-Vascular Endothelial Growth Factor Therapeutics Market 2023 - By Size, Share, Trends Analysis And Forecast Report 2032

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2023 identifies increase in the prevalence of ophthalmic diseases as the major driver for the Anti-Vascular Endothelial Growth Factor Therapeutics market's growth in the forecast period. The prevalence of ophthalmic diseases refers to the number or proportion of individuals within a given population who have been diagnosed with or exhibit specific eye conditions or diseases. Anti-vascular endothelial growth factor (VEGF) therapeutics help reduce the prevalence of ophthalmic diseases by effectively treating ailments such as wet age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion.

The global anti-vascular endothelial growth factor therapeutics market size is expected to grow from $12.01 billion in 2022 to $12.18 billion in 2023 at a compound annual growth rate (CAGR) of 1.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global anti-vascular endothelial growth factor therapeutics market size is expected to reach $12.8 billion in 2027 at a CAGR of 1.2%.

Download Free Sample Of Anti-Vascular Endothelial Growth Factor Therapeutics Market Report - https://www.thebusinessresearchcompany.com/sample_request?id=10683&type=smp

Major competitors in the Anti-Vascular Endothelial Growth Factor Therapeutics market are F. Hoffmann-La Roche AG, Biogen Inc., Pfizer Inc., Coherus BioSciences Inc., Applied Molecular Genetics Inc.

A key trend in the Anti-Vascular Endothelial Growth Factor Therapeutics market includes advancements in therapeutics. Companies operating in the anti-vascular endothelial growth factor therapeutics market are adopting advanced therapeutics to sustain their position in the market. For instance, in May 2022, Ashvattha Therapeutics Inc, a US-based clinical-stage biopharmaceutical company, released phase 1 safety data for healthy subjects for subcutaneous anti-VEGF wet AMD (age-related macular degeneration) and DME (diabetic macular edema) candidates. D-4517.2 therapy is a first-in-class therapy developed to address the unmet needs of DME conditions. D-4517.2 therapy is being developed for self-administration using an autoinjector. The autoinjector D-4517.2 enable patients to self-administer the medication once a month in the comfort of their home.

Read More On The Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report

The Anti-Vascular Endothelial Growth Factor Therapeutics market is segmented -

• By Product: Eylea, Lucentis, Beovu
• By Disease: Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration
• By End Users: Hospitals, Clinics, Oncology Centers, Other End Users
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Anti-Vascular Endothelial Growth Factor Therapeutics market.

The Business Research Company's "Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Anti-Vascular Endothelial Growth Factor Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10683

The Table Of Content For The Anti-Vascular Endothelial Growth Factor Therapeutics Market Include:

1. Executive Summary
2. Anti-Vascular Endothelial Growth Factor Therapeutics Market Characteristics
3. Anti-Vascular Endothelial Growth Factor Therapeutics Market Trends And Strategies
4. Anti-Vascular Endothelial Growth Factor Therapeutics Market - Macro Economic Scenario
5. Anti-Vascular Endothelial Growth Factor Therapeutics Market Size And Growth
………………………………………
26. Africa Anti-Vascular Endothelial Growth Factor Therapeutics Market
27. Anti-Vascular Endothelial Growth Factor Therapeutics Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Anti-Vascular Endothelial Growth Factor Therapeutics Market
29. Anti-Vascular Endothelial Growth Factor Therapeutics Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.